Literature DB >> 22407492

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Seong-Su Moon1, Young-Sil Lee, Sung Woo Kim.   

Abstract

Osteoporosis is a disease associated with insulin resistant states such as central obesity, diabetes, and metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) is also increased in such conditions. However, little is known about whether osteoporosis and nonalcoholic fatty liver disease are etiologically related to each other or not. We examined whether bone mineral density (BMD) is associated with NAFLD in pre- and postmenopausal women. Four hundred eighty-one female subjects (216 premenopausal and 265 postmenopausal) were enrolled. Lumbar BMD was measured using dual-energy X-ray absorptiometry. Liver ultrasonography was done to check the severity of fatty liver. We excluded subjects with a secondary cause of liver disease. Blood pressure, lipid profile, fasting plasma glucose, alanine aminotransferase (ALT), aspartate aminotransferase, and body mass index were measured in every subject. Mean lumbar BMD was lower in subjects with NAFLD than those without NAFLD in postmenopausal women (0.98 ± 0.01 vs. 1.01 ± 0.02 g/cm², P = 0.046). Multiple correlation analysis revealed a significant association between mean lumbar BMD and NAFLD in postmenopausal subjects after adjusting for age, body mass index, ALT, smoking status, and alcohol consumption (β coefficient -0.066, 95% CI -0.105 to -0.027, P = 0.001). Even after adjusting the presence of metabolic syndrome, the significance was maintained (β coefficient -0.043, 95% CI -0.082 to -0.004, P = 0.031). Lumbar BMD is related with NAFLD in postmenopausal females. We suggest that postmenopausal women with NAFLD may have a higher risk of osteoporosis than those without.

Entities:  

Mesh:

Year:  2012        PMID: 22407492     DOI: 10.1007/s12020-012-9639-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

2.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

Review 3.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

4.  Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

Authors:  C Loguercio; V De Girolamo; I de Sio; C Tuccillo; A Ascione; F Baldi; G Budillon; L Cimino; A Di Carlo; M P Di Marino; F Morisco; F Picciotto; L Terracciano; R Vecchione; V Verde; C Del Vecchio Blanco
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

5.  Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults.

Authors:  Seung H Park; Woo K Jeon; Sang H Kim; Hong J Kim; Dong I Park; Yong K Cho; In K Sung; Chong I Sohn; Dong K Keum; Byung I Kim
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

6.  Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women.

Authors:  Yun Kyung Jeon; Jeong Gyu Lee; Sang Soo Kim; Bo Hyun Kim; Seong-Jang Kim; Yong Ki Kim; In Joo Kim
Journal:  Endocr J       Date:  2011       Impact factor: 2.349

7.  Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.

Authors:  C Loguercio; T De Simone; M V D'Auria; I de Sio; A Federico; C Tuccillo; A M Abbatecola; C Del Vecchio Blanco
Journal:  Dig Liver Dis       Date:  2004-06       Impact factor: 4.088

8.  Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.

Authors:  J A Cuthbert; C Y Pak; J E Zerwekh; K D Glass; B Combes
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

9.  Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.

Authors:  C H Janes; E R Dickson; R Okazaki; S Bonde; A F McDonagh; B L Riggs
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women.

Authors:  Kyong-Chol Kim; Dong-Hyuk Shin; Sei-Young Lee; Jee-Aee Im; Duk-Chul Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

View more
  49 in total

1.  Assessment of endothelial function in patients with nonalcoholic fatty liver disease.

Authors:  Yasar Colak; Ebubekir Senates; Atakan Yesil; Yusuf Yilmaz; Oguzhan Ozturk; Levent Doganay; Ender Coskunpinar; Ozlem Timirci Kahraman; Banu Mesci; Celal Ulasoglu; Ilyas Tuncer
Journal:  Endocrine       Date:  2012-06-03       Impact factor: 3.633

Review 2.  The association between metabolic syndrome and bone mineral density: a meta-analysis.

Authors:  Peng Xue; Ping Gao; Yukun Li
Journal:  Endocrine       Date:  2012-05-01       Impact factor: 3.633

Review 3.  Osteoporosis across chronic liver disease.

Authors:  M Guarino; I Loperto; S Camera; V Cossiga; C Di Somma; A Colao; N Caporaso; F Morisco
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

Review 4.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

5.  Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block.

Authors:  Giovanni Musso
Journal:  Endocrine       Date:  2012-07-18       Impact factor: 3.633

Review 6.  Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.

Authors:  Sikarin Upala; Veeravich Jaruvongvanich; Karn Wijarnpreecha; Anawin Sanguankeo
Journal:  J Bone Miner Metab       Date:  2016-12-07       Impact factor: 2.626

7.  Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults.

Authors:  S H Lee; J M Yun; S H Kim; Y G Seo; H Min; E Chung; Y S Bae; I S Ryou; B Cho
Journal:  J Endocrinol Invest       Date:  2016-08-25       Impact factor: 4.256

8.  Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.

Authors:  Zhongbo Liu; Tianzhen Han; Haim Werner; Clifford J Rosen; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2017-11-06       Impact factor: 6.741

Review 9.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 10.  Should we abandon statins in the prevention of bone fractures?

Authors:  Katherine Esposito; Annalisa Capuano; Liberata Sportiello; Andrea Giustina; Dario Giugliano
Journal:  Endocrine       Date:  2013-03-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.